Pharmacovigilance 2022

Pharmacovigilance Services Overview.

Arriello’s global and local pharmacovigilance services.

Local expertise, global footprint.

If you’re looking for a partner for your journey to market, and throughout the life cycle of your product, we understand you. 

Our ability to provide a tailored, focused small-company service, allied to the ability to help drive large projects with scale and footprint is unmatched in the industry. 

Nobody else is better positioned than Arriello to provide the personalized and attentive service needed across the product life cycle. 

And of course, our unique advisory board is on-hand to provide impartial advice based on their deep global experience and expertise across all areas throughout your journey.

Different stages, different focus.

During your early-stage development our focus is on building a relationship based on trust and delivery. 

We know you have investor commitments and deadlines to meet, so you need assurance and reliability, the peace of mind that comes from a wealth of expert advice backed up with on-time project deliverables. Every time. 

Often you won’t yet have your pharmacovigilance and regulatory heads and processes in place, so trust is critical. At later stages you need to know we have the breadth of services, experience, and track record to expand and grow with your needs, keeping that continuity and commitment in place for the journey. 

Those are Arriello trademarks, along with communications, and are key to your, and our, long term success. 

We understand your needs and regardless of which stage you’re at, our expertise and clear and transparent approach to systems means you can be confident that together we can ensure control and oversight of your PV system and patient safety.

Tailored to you, for the long run.

Our robust QMS together with our team of Project Managers means we can adapt our system to your project needs easily and efficiently. We keep you compliant and minimize and manage the risks to patients, and of course, your products. 

We also know that communication is often at the center of a successful relationship. It’s at the core of our project management approach. How often? In what detail? Does it fit your expectations? 

Ultimately, we focus on building a strong strategic partnership with you that provides a true faster, better, smarter service across the whole product life cycle, not just on an individual project.

 

Download our Pharmacovigilance services brochure…

Why choose Arriello.

In this video, Arriello’s VP of Global Drug Safety Kieran O’Donnell talks about why Arriello is unique in the industry in offering strategic consulting alongside a range of expert drug safety services.

We are deliberately moving towards establishing ourselves, not just as a Drug Safety service provider, but as a strategic partner that can add optimal value to our clients, now and over the long term. This allows us to move away from being purely transactional, towards being a true partner from development to market, across all aspects of Drug Safety.

Kieran O'Donnell Why choose Arriello

Click an area to see the countries where we operate…

European and Russian coverage
Albania
Austria
Belarus
Belgium
Bosnia and Herzegovina
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Georgia
Germany
Greece
Hungary
Iceland
Ireland
Italy
Kosovo
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Moldova
Montenegro
Netherlands
Northern Macedonia
Norway
Poland
Portugal
Romania
Russian Federation
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Ukraine
United Kingdom
Asia
Armenia
Azerbajan
Bahrain
Bangladesh
Brunei Darussalam
China
Hong Kong
India
Indonesia
Iran
Iraq
Israel
Japan
Jordan
Kazakhstan
Kuwait
Kyrgyzstan
Lebanon
Macao
Malaysia
Mongolia
North Korea
Oman
Pakistan
Palestine
Philippines
Qatar
Saudi Arabia
Singapore
South Korea
Syrian Arab Republic
Taiwan
Tajikistan
Thailand
Turkey
Turkmenistan
UAE
Uzbekistan
Vietnam
Yemen
Oceania / Pacific
Australia
New Zealand
South America
Argentina
Aruba
Bolivia
Brazil
Chile
Colombia
Costa Rica
Curaçao
Dominican Republic
Ecuador
El Salvador
Falkland Islands
French Guiana
Guatemala
Guyana
Honduras
Nicaragua
Panama
Paraguay
Peru
Puerto Rico
Suriname
Trinidad & Tobago
Uruguay
Venezuela
North America
Bahamas
Barbados
Belize
Canada
Jamaica
Mexico
USA
Africa
Algeria
Botswana
Burkina Faso
Cameroon
Congo
Egypt
Ethiopia
Gabon
Ghana
Guinea
Kenya
Libya
Madagascar
Malawi
Mali
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Nigeria
Rwanda
Senegal
South Africa
Sudan
Swaziland
Tanzania
Togo
Tunisia
Uganda
Zimbabwe
North & Central America South America Africa Oceania & Pacific Europe & Russia Asia
European and Russian coverage

Albania
Austria
Belarus
Belgium
Bosnia and Herzegovina
Bulgaria
Croatia
Cyprus
Czech Republic
Denmark
Estonia
Finland
France
Georgia
Germany
Greece
Hungary
Iceland
Ireland
Italy
Kosovo
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Moldova
Montenegro
Netherlands
Northern Macedonia
Norway
Poland
Portugal
Romania
Russian Federation
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Ukraine
United Kingdom

Asia

Armenia
Azerbajan
Bahrain
Bangladesh
Brunei Darussalam
China
Hong Kong
India
Indonesia
Iran
Iraq
Israel
Japan
Jordan
Kazakhstan
Kuwait
Kyrgyzstan
Lebanon
Macao
Malaysia
Mongolia
North Korea
Oman
Pakistan
Palestine
Philippines
Qatar
Saudi Arabia
Singapore
South Korea
Syrian Arab Republic
Taiwan
Tajikistan
Thailand
Turkey
Turkmenistan
UAE
Uzbekistan
Vietnam
Yemen

Oceania / Pacific

Australia
New Zealand

South America

Argentina
Aruba
Bolivia
Brazil
Chile
Colombia
Costa Rica
Curaçao
Dominican Republic
Ecuador
El Salvador
Falkland Islands
French Guiana
Guatemala
Guyana
Honduras
Nicaragua
Panama
Paraguay
Peru
Puerto Rico
Suriname
Trinidad & Tobago
Uruguay
Venezuela

North America

Bahamas
Barbados
Belize
Canada
Jamaica
Mexico
USA

Africa

Algeria
Botswana
Burkina Faso
Cameroon
Congo
Egypt
Ethiopia
Gabon
Ghana
Guinea
Kenya
Libya
Madagascar
Malawi
Mali
Mauritania
Mauritius
Morocco
Mozambique
Namibia
Nigeria
Rwanda
Senegal
South Africa
Sudan
Swaziland
Tanzania
Togo
Tunisia
Uganda
Zimbabwe

Ready to contact us?

Latest case studies.

View all
ICSRs, Local literature screening, Regulatory intelligence
Strategic Planning case study
Local literature search, ICSR processing, Regulatory intelligence
A bespoke cloud based system TH
Local PV, regulatory strategy
Complex pharmacovigilance local support

What our clients say about us.